MRK
Merck & Co., Inc.
NYSEHealthcareDrug Manufacturers - General
Last fetched on January 28, 2026 at 03:09 AM UTC
Score History
MRK performance over the last 31 data points
Screen Score
Current rating and historical changes
Current Score
5d Change
30d Change
Price & Valuation
Current pricing and fair value estimate
Current Price
$107.92
Fair Value Estimate
$120.00
Market Cap
$269.56B
Valuation Ratios
Key valuation metrics
P/E Ratio
14.26
80th percentileP/B Ratio
5.18
50th percentileEV/EBITDA
9.23
50th percentileFCF Yield
5.39%
40th percentileProfitability
Profit margins and returns
ROE
32.63%
70th percentileOperating Margin
40.80%
80th percentileGross Margin
77.85%
80th percentileEPS
$7.57
90th percentileGrowth
Revenue and earnings growth rates
Revenue Growth
3.70%
60th percentileEarnings Growth
87.00%
70th percentileFinancial Health
Balance sheet and financial stability
Current Ratio
1.66
70th percentileDebt-to-Equity
0.01:1
70th percentileBeta
0.44
0th percentile